Chief Executive Officer
Mr. Michlin brings two decades of experience in growing biomedical organizations. His proficiency in corporate finance, capital markets and business management and development has played a crucial role in the success of leading organizations throughout the Israeli biotech industry. He joined Brainsway in 2015 serving as a director on its board providing exceptional guidance. He brings extensive expertise in steering biomedical companies to success. Yaacov possesses the right blend of strategic acumen, interpersonal skills, relationship assets and management capabilities. For the past eight years, Mr. Michlin has served as president and CEO of Yissum, the technology transfer company of Israel's Hebrew University in Jerusalem. At Yissum, he facilitated and oversaw numerous corporate transactions and initiatives in partnership with corporations across the globe and funded and served as chairman of few companies including Integra Holdings, a healthcare investment company and Agrinnovation an investment fund focusing on Agriculture and food sciences. Mr. Michlin also served as chairman for QLIGHT Nanotech Ltd., a developer of semiconductors and nanocrystals, which he led from the company's founding until its acquisition by Merck. He also served as co-chairman of ITTN, the Israeli organization for technology transfer. Prior to Yissum, Mr. Michlin practiced as a corporate lawyer, advising on major corporate matters including mergers and acquisitions, capital raising and initial public offerings for clients including mainly Teva Pharmaceutical Industries. Mr. Michlin is a lawyer and economist by training, and holds an MBA from the Technion in high-tech company management.
Yiftach Roth, Ph.D
As one of Brainsway's founders, Yiftach Roth has served as the company's Research and Development Manager since May 2006, and as a member of the company's Board of Directors since November 2006. From 2003 through 2006, Dr. Roth worked in the Advanced Technology Center of the Chaim Sheba Medical Center at Tel Hashomer as a researcher in the field of Magnetic Resonance Imaging (MRI). Dr. Roth's primary research interests are TMS and Magnetic Resonance Imaging (MRI), and he was one of the two key inventors of Brainsway's patented Deep TMS coil. Dr. Roth holds B.Sc. and M.Sc. degrees in Physics and a Ph.D. in Medical Physics from Tel Aviv University.
Chief Technology Officer
Mr. Segal has more than 20 years of top leadership roles in various fields including vast hi-tech management experience in a wide range of leading technological groups. In 2004 he co-founded WiTech Communications Ltd., a company providing wireless video solutions for diverse commercial applications, where he served as a Vice President. Prior to this, Ronen served as projects leader for OpTun Inc., where he was responsible for the development of sophisticated fiber-optics communications active switching components. From 1998 to 2000, he worked for the Israeli Navy's development center on a state-of-the-art submarine data communication system. From 1994 to 1998, Mr. Segal served in the Israeli Ministry of Defense’s Advanced Technology Unit. He studied at the Jerusalem College of Technology as part of a special academic reserves project in electro-optical Engineering and applied physics.
Chief Financial Officer
Mr. Levy has over 15 years of experience in finance and administration. Prior to joining Brainsway, Mr. Levy served as Finance manager in the Latin America Division at Amdocs Ltd., responsible for accounting, financial reporting, treasury, portfolio management and finance support to Mergers & Acquisitions. Prior to Amdocs, Hadar Levy served as Chief Financial Officer & Business Development of Notal Vision, a healthcare company that researches and develops medical technologies for detecting retinal malfunction and deterioration, where he was responsible for all financial functions, and lead financial rounds of equity including M&A activities with strategic partners. Prior to this position, he served as Controller of GE Healthcare Israel. Mr. Levy began his career at Deloitte LLP, holds a BA in Accounting and Economics and an LLM degree from Bar Ilan University and is a Certified Public Accountant.
VP Field and Clinical Operations
Amit Ginou manages the Field and Clinical Operations at Brainsway. Prior to this, Amit served as the Clinical Trials Manager at Brainsway, conducting dozens of clinical trials at different phases to explore the efficacy and safety of Brainsway Deep TMS for diverse clinical indications. Amit holds a B.Sc. degree in Neuroscience from Bar-Ilan University, and an MA Law degree from Bar-Ilan University.
Vice President, Global Operations
Eliran Ron is Vice President, Global Operations for Brainsway and serves on the company’s Management Committee. He is responsible for leading Brainsway's Global Operations, Production, Logistics, Purchasing and Facilities. He joined Brainsway in 2009.Ron is working to drive expansion, efficiency and value creation efforts in a variety of operation roles. He has a record of assessing and diagnosing opportunities to capture value and institute new operational and service delivery models to seize efficiently at scale. His operations management background included creating and executing company plans. Ron studied for a degree in Finance and Accountancy at the Hebrew University of Jerusalem.
Chief Medical Officer
Dr. Tendler brings years of experience in the treatment of mental disorders as a psychiatrist. Dr. Tendler graduated in 2002 from State University of New York Downstate Medical School in Brooklyn with Distinction in Research. From 2002-2004, he trained at Tulane University in Internal Medicine and Psychiatry followed by two years at the University of Chicago in General Psychiatry, where he was chief resident of the consultation liaison service and course director for psychosomatic medicine. Dr. Tendler is Board Certified in General Psychiatry, Sleep Medicine and Behavioral Sleep Medicine . In 2006, Dr. Tendler established Advanced Mental Health Care Inc. in Florida, which has since served over 4000 patients in Palm Beach County, Florida. Dr. Tendler began using TMS clinically in 2009 for a variety of psychiatric and neurological conditions, and his clinical research sites participated in the clinical trial that led to Brainsway's FDA clearance. Currently, he has three clinical research sites studying the efficacy of Deep TMS for Bipolar Depression, Smoking Cessation, PTSD and OCD.
VP Sales Operations, North America
Joseph Perekupka is an award–winning sales and operations executive who designs and implements highly successful strategies and teams that drive revenue and improve market share within medical device and pharmaceutical sectors. Throughout his 20-year career, Mr. Perekupka held leadership positions in variety of companies, including Biotronik Inc., a company specializing in advanced cardiology devices, St. Jude Medical Inc., a cardiovascular manufacturing company, and Forest Laboratories, a company focusing on Manufacturing of Pharmaceutical products. In addition, he held management positions at Bristol-Meyers Squibb, Co. Mr. Perekupka earned a BA in Marketing from Pennsylvania State University and an MBA in Management and Finance from The Gabelli School of Business at Fordham University.